Target intelligence / Profile preview

Foot-and-mouth disease virus serotype A (FMDV-A)

Target
FMDV-A
Molecular classification
Virus, Picornaviridae, Aphthovirus
01

Overview

Foot-and-mouth disease virus serotype A (FMDV-A) is a highly contagious pathogen belonging to the Aphthovirus genus of the Picornaviridae family [1, 8]. It is one of the seven major serotypes responsible for foot-and-mouth disease, a severe vesicular condition affecting cloven-hoofed animals such as cattle, pigs, and sheep [4, 12]. The virus consists of a positive-sense single-stranded RNA genome enclosed in a non-enveloped icosahedral capsid [8, 13]. FMDV-A initiates infection by binding to host cell integrin receptors via a conserved Arg-Gly-Asp (RGD) motif on its VP1 capsid protein [2, 14]. Once inside the host cell, the viral genome is translated into a single polyprotein that is subsequently cleaved by viral proteases, including the 3C protease, into functional structural and non-structural proteins [8, 16]. Therapeutic interventions primarily involve the use of inactivated virus vaccines, which are often serotype-specific due to the high rate of antigenic variation [5, 15]. Experimental antiviral drugs, such as ribavirin and specific protease inhibitors, are also being investigated to target viral replication and processing [11, 16]. Control of FMDV-A is critical for the livestock industry due to its rapid transmission and the significant economic impact of outbreaks [10, 20].

Other names
FMDV serotype AAphthovirus AVallée A
02

Mechanism of action

Inhibition of RNA-dependent RNA polymerase (3Dpol), inhibition of viral 3C protease, and neutralization of viral capsid proteins to prevent host cell entry.

03

Biological functions

Viral replicationHost cell entryImmune evasionViral protein processing
04

Disease associations

InfectionFoot-and-mouth disease
05

Safety considerations

High contagiousnessAntigenic variationLaboratory biosafety risk (BSL-3/4)Lack of cross-serotype protection
06

Interacting drugs

Ribavirin

5 more in the full profile.

07

Biomarkers

FMDV RNA (RT-PCR)FMDV antigen (ELISA)3ABC non-structural protein antibodies

Beyond the preview

Go deeper on Foot-and-mouth disease virus serotype A (FMDV-A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Foot-and-mouth disease virus serotype A (FMDV-A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call